Abstract
This case report describes authors own experience of clinical mamgmemt of the patient with depressive disorder and systemic lupus erytematosus (SLE).
Full-text of the article is available for this locale: Українська.
References
- World Health Organization. Depression and Other Common Mental Disorders:Global Health Estimates. Geneva: WHO; 2017. URL: https://apps.who.int/iris/bitstream/handle/10665/254610/WHO-MSD-MER-2017.2-eng.pdf
- Naprjejenko OK, Loganovs'kyy̆ KM, Syropjatov OG. Non-circular depressions: monograph. Kyiv:Sofija-А;2013:624.
- O’Neal MA. Neurology and Psychiatry of Women. Basel: Springer International Publishing; 2019.
- Moustafa AT, Moazzami M, Engel L, et al. Prevalence and metric of depression and anxiety in systemic lupus erythematosus: A systematic review and meta-analysis. Semin Arthritis Rheum. 2019;2(1). DOI: https://doi.org/10.1016/j.semarthrit.2019.06.017 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31303437
- Pharmaceuticals PLC. Instructions for medical treatment of venlafaxine. Kormend: EGIS;2000. URL: https://apteka.doctorok.com.ua/instructions/200672.pdf
- Bertsias GK, Ioannidis JP, Aringer M, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010;69(12):2074-82. DOI: https://doi.org/10.1136/ard.2010.130476 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20724309
- Lotrich FE. Inflammatory cytokine-associated depression. Brain Res. 2015;1617:113-25. DOI: https://doi.org/10.1016/j.brainres.2014.06.032 PMID: https://www.ncbi.nlm.nih.gov/pubmed/25003554